Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts

European Journal of Pharmacology

Volumn 593, Issue 1-3, 2008, Pages 24-29

  Chen, Yen Ling ^a,b   Liu, Ju Chi ^b   Loh, Shih Hurng ^a   Chen, Cheng Hsien ^b   Hong, Chuang Ye ^b   Chen, Jin Jer ^c   Cheng, Tzu Hurng ^d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Epidermal growth factor receptor; Extracellular signal regulated kinase; Rat cardiac fibroblasts; Urotensin II

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLCYSTEINE; DIPHENYLIODONIUM SALT; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; UROTENSIN II;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; HEART MUSCLE CELL; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLOW CYTOMETRY; IMMUNOPRECIPITATION; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TYROSINE; UROTENSINS;

EID: 49749096009     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.025     Document Type: Article

References (22)

1. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., Louden C.S., Foley J.J., Sauermelch C.F., Coatney R.W., Ao Z., Disa J., Holmes S.D., Stadel J.M., Martin J.D., Liu W.S., Glover G.I., Wilson S., McNulty D.E., Ellis C.E., Elshourbagy N.A., Shabon U., Trill J.J., Hay D.W., Ohlstein E.H., Bergsma D.J., and Douglas S.A. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
2. Bousette N., and Giaid A. Urotensin-II and cardiovascular diseases. Curr. Hypertens. Rep. 8 (2006) 479-483
3. Bousette N., Pottinger J., Ramli W., Ohlstein E.H., Dhanak D., Douglas S.A., and Giaid A. Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease. Peptides 27 (2006) 2919-2926
4. Chao H.H., Hong H.J., Liu J.C., Lin J.W., Chen Y.L., Chiu W.T., Wu C.H., Shyu K.G., and Cheng T.H. Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Eur. J. Pharmacol. 573 (2007) 49-54
5. Chen C.H., Cheng T.H., Lin H., Shih N.L., Chen Y.L., Chen Y.S., Cheng C.F., Lian W.S., Meng T.C., Chiu W.T., and Chen J.J. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol. Pharmacol. 69 (2006) 1347-1355
6. Cheng C.M., Hong H.J., Liu J.C., Shih N.L., Juan S.H., Loh S.H., Chan P., Chen J.J., and Cheng T.H. Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol. Pharmacol. 63 (2003) 1002-1011
7. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., and Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 42 (2003) 1845-1854
8. Cheng T.H., Shih N.L., Chen S.Y., Wang D.L., and Chen J.J. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc. Res. 41 (1999) 654-662
9. Cleutjens J.P., Verluyten M.J., Smiths J.F., and Daemen M.J. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 147 (1995) 325-338
10. Diez J., Lopez B., Gonzalez A., and Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr. Opin. Cardiol. 16 (2001) 328-335
11. Djordjevic T., BelAiba R.S., Bonello S., Pfeilschifter J., Hess J., and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 519-525
12. Eghbali M. Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation. Basic. Res. Cardiol. 87 Suppl 2 (1992) 183-189
13. Litwin S.E., and Grossman W. Diastolic dysfunction as a cause of heart failure. J. Am. Coll. Cardiol. 22 4 Suppl A (1993) 49A-55A
14. Matsushita M., Shichiri M., Fukai N., Ozawa N., Yoshimoto T., Takasu N., and Hirata Y. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144 (2003) 1825-1831
15. Papadopoulos P., Bousette N., and Giaid A. Urotensin-II and cardiovascular remodeling. Peptides 29 (2008) 764-769
16. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
17. Saka M., Obata K., Ichihara S., Cheng X.W., Kimata H., Nishizawa T., Noda A., Izawa H., Nagata K., Murohara T., and Yokota M. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure. J. Cardiovasc. Pharmacol. 47 (2006) 770-779
18. Tolle M., and van der Giet M. Cardiorenovascular effects of urotensin II and the relevance of the UT receptor. Peptides 29 (2008) 743-763
19. Tzanidis A., Hannan R.D., Thomas W.G., Onan D., Autelitano D.J., See F., Kelly D.J., Gilbert R.E., and Krum H. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ. Res. 93 (2003) 246-253
20. Zhang Y.G., Li Y.G., Liu B.G., Wei R.H., Wang D.M., Tan X.R., Bu D.F., Pang Y.Z., and Tang C.S. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta. Pharmacol. Sin. 28 (2007) 36-43
21. Zoccali C., Mallamaci F., Benedetto F.A., Tripepi G., Pizzini P., Cutrupi S., and Malatino L. Urotensin II and cardiomyopathy in end-stage renal disease. Hypertension 51 (2008) 326-333
22. Zou Y., Nagai R., and Yamazaki T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 508 (2001) 57-60